128 results on '"Loza, Elena"'
Search Results
2. High MICs for vancomycin and daptomycin and complicated catheter-related bloodstream infections with methicillin-sensitive Staphylococcus aureus
3. Long-term clonal dynamics of Enterococcus faecium strains causing bloodstream infections (1995–2015) in Spain
4. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates
5. Real Life Clinical Impact of Antimicrobial Stewardship Actions on the Blood Culture Workflow from a Microbiology Laboratory
6. Modificaciones inmediatas en la dinámica uterina tras la realización de la técnica de equilibración de la sincondrosis esfenobasilar según Upledger
7. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
8. Modificaciones en la presión intraocular y la presión arterial en pacientes con diabetes mellitus tipo 1 tras la manipulación global occipucio-atlas-axis según Fryette. Ensayo clínico aleatorizado
9. Школа, открытая для всех
10. Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018)
11. Школа, открытая для всех
12. A 21-year survey of Escherichia coli from bloodstream infections (BSIs) in a tertiary hospital reveals how community-hospital dynamics, influence local BSI rates, the trends of the B2 phylogroup and the STc131 pandemic clone
13. A 21-year survey ofEscherichia colifrom bloodstream infections (BSIs) in a tertiary hospital reveals how community-hospital dynamics of the B2 phylogroup clones influence local BSI rates
14. High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000–07)
15. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
16. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin
17. Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium
18. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000
19. Evolución de la sensibilidad y de los aislados productores de β-lactamasas de espectro extendido en microorganismos gramnegativos en el estudio SMART en España (2011-2015)
20. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum beta-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015)
21. Relación entre la Gestión de Adquisiciones y Contrataciones y la Ejecución Presupuestal en la Dirección Regional de Salud de Madre de Dios - 2017
22. A multicentre study investigating parameters which influence direct bacterial identification from urine
23. Monitoring the antimicrobial susceptibility of Gramnegative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
24. Efectos del tratamiento osteopático aplicado en los trastornos de la fertilidad
25. Long-term clonal dynamics ofEnterococcus faeciumstrains causing bloodstream infections (1995–2015) in Spain
26. High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-SensitiveStaphylococcus aureus
27. Bacteremic Pneumonia before and after Withdrawal of 13-Valent Pneumococcal Conjugate Vaccine from a Public Vaccination Program in Spain: A Case-Control Study
28. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain
29. Temocillin: In Vitro Activity Compared with Other Antibiotics
30. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).
31. Sensibilidad de microorganismos gramnegativos de infecciones intraabdominales y evolución de los aislados con β-lactamasas de espectro extendido en el estudio smart en españa (2002-2010)
32. Antimicrobial susceptibility of gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum β-lactamases in the smart study in spain (2002-2010)
33. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain
34. Efectos del tratamiento osteopático aplicado en los trastornos de la fertilidad
35. Reidentification of Streptococcus bovis Isolates Causing Bacteremia According to the New Taxonomy Criteria: Still an Issue?
36. Quality control for β-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain
37. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia
38. Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006)
39. Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms
40. Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline
41. Breakpoints for Predicting Pseudomonas aeruginosa Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High-Range Etest Strips
42. Population Structure of Enterococcus faecium Causing Bacteremia in a Spanish University Hospital: Setting the Scene for a Future Increase in Vancomycin Resistance?
43. Evolución del patrón de sensibilidad de aislados de Escherichia coli en urocultivos procedentes del medio hospitalario y extrahospitalario
44. Fluoroquinolone-Resistant Streptococcus pneumoniae in Spain: Activities of Garenoxacin against Clinical Isolates Including Strains with Altered Topoisomerases
45. Quality Control for β-Lactam Susceptibility Testing with a Well-Defined Collection of Enterobacteriaceae and Pseudomonas aeruginosa Strains in Spain
46. Actividad in vitro comparativa de garenoxacino (BMS-284756). Programa SENTRY España (1999-2000)
47. In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms
48. Validation of the VITEK2 and the advance expert system with a collection of enterobacteriaceae harboring extended spectrum or inhibitor resistant β-lactamases
49. In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia
50. Antimicrobial Susceptibilities of Unique Stenotrophomonas maltophilia Clinical Strains
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.